博拓生物 (688767.SH)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

利润表(单季度)(博拓生物)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2023年第三季度2023年第二季度2023年第一季度2022年第四季度2022年第三季度2022年第二季度2022年第一季度
上市前/上市后 上市后上市后上市后上市后上市后上市后上市后
报表类型 合并报表合并报表合并报表合并报表合并报表合并报表合并报表
一、营业总收入(元) 100,162,558.53108,390,472.22103,685,805.87144,479,564.82232,744,243.64506,652,281.471,017,267,845.08
 营业收入(元) 100,162,558.53108,390,472.22103,685,805.87144,479,564.82232,744,243.64506,652,281.471,017,267,845.08
二、营业总成本(元) 74,560,808.5249,819,037.2992,088,830.56213,390,288.7776,334,102.07215,876,684.93445,116,101.97
 营业成本(元) 56,260,018.6665,922,271.8659,197,553.49161,991,423.15103,806,006.52219,974,335.15399,004,906.38
 研发费用(元) 15,156,563.7118,708,822.399,880,272.8314,933,477.8123,965,986.7849,722,465.8719,586,991.87
 营业税金及附加(元) 195,344.661,772,408.022,146,906.727,529,373.791,855,435.214,068,112.486,035,630.69
 销售费用(元) 6,012,450.295,453,071.415,610,266.227,193,552.314,709,166.929,416,549.997,146,653.74
 管理费用(元) 13,553,257.2212,432,789.8010,893,383.4717,971,991.6713,423,662.7913,748,618.4212,482,729.30
 财务费用(元) -16,616,826.02-54,470,326.194,360,447.833,770,470.04-71,426,156.15-81,053,396.98859,189.99
 资产减值损失(元) -123,521.20-7,017,617.01-661,285.63-65,184,684.20-611,512.77-7,199,002.85-914,956.96
 信用减值损失(元) -731,955.14-1,601,070.77-609,805.111,234,341.14622,817.293,190,511.40434,991.66
三、其他经营收益
 加:公允价值变动收益(元) --1,788,018.431,723,502.30-6,534,939.251,505,772.00-1,590,882.026,684,565.40
 加:投资收益(元) 389,260.262,990,618.57364,931.525,421,800.973,989,041.084,990,080.22388,800.00
 资产处置收益(元) 852.81------
 其他收益(元) 661,557.49288,064.911,542,649.417,427,594.131,870,659.894,021,882.254,169,602.35
四、营业利润(元) 25,797,944.2351,338,893.6313,956,967.80-126,546,611.16163,786,919.06294,188,185.54582,914,745.56
 加:营业外收入(元) 7,938,053.104,761,532.309,450.00-808,365.0012,575.36797,805.988,419.27
 减:营业外支出(元) 340,778.27-295,160.45295,237.015,948,730.4051,716.544,725,626.821,730,438.36
五、利润总额(元) 33,395,219.0656,395,586.3813,671,180.79-133,303,706.56163,747,777.88290,260,364.70581,192,726.47
 减:所得税费用(元) 4,297,258.896,934,823.302,168,938.40-21,460,908.8223,695,475.5938,473,159.8087,605,381.23
六、净利润(元) 29,097,960.1749,460,763.0811,502,242.39-111,842,797.74140,052,302.29251,787,204.90493,587,345.24
(一)按经营持续性分类
  持续经营净利润(元) 29,097,960.1749,460,763.0811,502,242.39-111,842,797.74140,052,302.29251,787,204.90493,587,345.24
(二)按所有权归属分类
  归属于母公司股东的净利润(元) 29,925,011.2749,703,499.6311,899,389.65-111,132,294.66139,820,111.96252,437,637.46492,528,719.71
  少数股东损益(元) -827,051.10-242,736.55-397,147.26-710,503.08232,190.33-650,432.561,058,625.53
 扣除非经常性损益后的净利润(元) 22,573,407.6944,227,102.219,055,122.92-111,533,913.45133,590,700.65249,457,724.09484,445,824.96
七、每股收益
 一、基本每股收益(元) 0.280.470.11-1.041.312.364.62
 二、稀释每股收益(元) 0.280.470.11-1.041.312.364.62
八、其他综合收益(元) -127,824.12436,487.87707,863.98-1,014,634.50901,193.73690,596.75-13,550.40
 归属于母公司股东的其他综合收益(元) -115,041.72392,839.08637,077.59-913,171.05811,074.35621,537.08-12,195.36
 归属于少数股东的其他综合收益(元) -12,782.4043,648.7970,786.39-101,463.4590,119.3869,059.67-1,355.04
九、综合收益总额(元) 28,970,136.0549,897,250.9512,210,106.37-112,857,432.24140,953,496.02252,477,801.65493,573,794.84
 归属于母公司所有者的综合收益总额(元) 29,809,969.5550,096,338.7112,536,467.24-112,045,465.71140,631,186.31253,059,174.54492,516,524.35
 归属于少数股东的综合收益总额(元) -839,833.51-199,087.76-326,360.87-811,966.53322,309.71-581,372.891,057,270.49
公告日期 2023-10-282023-08-302023-04-292023-04-292022-10-292022-08-302022-04-28
审计意见(境内) 标准无保留意见

前瞻产业研究院